|
1
|
[Extrapancreatic tumors in intraductal papillary mucinous neoplasm of the pancreas].
|
Korean J Gastroenterol
|
2009
|
1.48
|
|
2
|
Phase IIb multicentred randomised trial of besifovir (LB80380) versus entecavir in Asian patients with chronic hepatitis B.
|
Gut
|
2013
|
1.46
|
|
3
|
Prospective validation of P2/MS noninvasive index using complete blood counts for detecting oesophageal varices in B-viral cirrhosis.
|
Liver Int
|
2010
|
1.46
|
|
4
|
Hepatitis B virus infection after renal transplantation in the presence of antibody to hepatitis B surface antigen immunity.
|
J Gastroenterol Hepatol
|
2004
|
1.39
|
|
5
|
Usefulness of FibroScan for detection of early compensated liver cirrhosis in chronic hepatitis B.
|
Dig Dis Sci
|
2008
|
1.35
|
|
6
|
Twenty-four-week clevudine therapy showed potent and sustained antiviral activity in HBeAg-positive chronic hepatitis B.
|
Hepatology
|
2007
|
1.33
|
|
7
|
Validation of FIB-4 and comparison with other simple noninvasive indices for predicting liver fibrosis and cirrhosis in hepatitis B virus-infected patients.
|
Liver Int
|
2010
|
1.25
|
|
8
|
Clevudine is highly efficacious in hepatitis B e antigen-negative chronic hepatitis B with durable off-therapy viral suppression.
|
Hepatology
|
2007
|
1.21
|
|
9
|
Comparison of rifaximin and lactulose for the treatment of hepatic encephalopathy: a prospective randomized study.
|
Yonsei Med J
|
2005
|
1.17
|
|
10
|
A liver stiffness measurement-based, noninvasive prediction model for high-risk esophageal varices in B-viral liver cirrhosis.
|
Am J Gastroenterol
|
2010
|
1.15
|
|
11
|
Long-term outcome of chronic hepatitis B based on histological grade and stage.
|
J Gastroenterol Hepatol
|
2007
|
1.15
|
|
12
|
Risk assessment of esophageal variceal bleeding in B-viral liver cirrhosis by a liver stiffness measurement-based model.
|
Am J Gastroenterol
|
2011
|
1.14
|
|
13
|
How can we enhance the performance of liver stiffness measurement using FibroScan in diagnosing liver cirrhosis in patients with chronic hepatitis B?
|
J Clin Gastroenterol
|
2010
|
1.12
|
|
14
|
Lamivudine maintenance beyond one year after HBeAg seroconversion is a major factor for sustained virologic response in HBeAg-positive chronic hepatitis B.
|
Hepatology
|
2010
|
1.11
|
|
15
|
Transitional features of histologic type of non-alcoholic fatty liver disease in Korean young men.
|
J Gastroenterol Hepatol
|
2012
|
1.07
|
|
16
|
Hepatic stellate cells primed with cytokines upregulate inflammation in response to peptidoglycan or lipoteichoic acid.
|
Lab Invest
|
2006
|
1.04
|
|
17
|
PIVKA-II is a useful tumor marker for recurrent hepatocellular carcinoma after surgical resection.
|
Oncology
|
2007
|
1.04
|
|
18
|
Association of genetic variations in CCR5 and its ligand, RANTES with clearance of hepatitis B virus in Korea.
|
J Med Virol
|
2006
|
1.03
|
|
19
|
Partial virological response to entecavir in treatment-naive patients with chronic hepatitis B.
|
Antivir Ther
|
2011
|
1.02
|
|
20
|
CD11b(+) Gr1(+) bone marrow cells ameliorate liver fibrosis by producing interleukin-10 in mice.
|
Hepatology
|
2012
|
1.01
|
|
21
|
Anti-hepatitis A virus seroprevalence among patients with chronic viral liver disease in Korea.
|
Eur J Gastroenterol Hepatol
|
2007
|
0.99
|
|
22
|
[Management of Chronic Hepatitis B].
|
Korean J Hepatol
|
2007
|
0.99
|
|
23
|
Long-term clinical outcome of phase IIb clinical trial of percutaneous injection with holmium-166/chitosan complex (Milican) for the treatment of small hepatocellular carcinoma.
|
Clin Cancer Res
|
2006
|
0.98
|
|
24
|
Usefulness of urine strip test in the rapid diagnosis of spontaneous bacterial peritonitis.
|
Liver Int
|
2005
|
0.97
|
|
25
|
Acute cholecystitis at T2-weighted and manganese-enhanced T1-weighted MR cholangiography: preliminary study.
|
Radiology
|
2003
|
0.97
|
|
26
|
Clinical characteristics and prognosis of hepatocellular carcinoma with different sets of serum AFP and PIVKA-II levels.
|
Eur J Gastroenterol Hepatol
|
2012
|
0.95
|
|
27
|
A novel liver stiffness measurement-based prediction model for cirrhosis in hepatitis B patients.
|
Liver Int
|
2010
|
0.94
|
|
28
|
Apoptosis of hepatic stellate cells in carbon tetrachloride induced acute liver injury of the rat: analysis of isolated hepatic stellate cells.
|
J Hepatol
|
2003
|
0.94
|
|
29
|
Autologous bone marrow infusion activates the progenitor cell compartment in patients with advanced liver cirrhosis.
|
Cell Transplant
|
2010
|
0.92
|
|
30
|
The usefulness of liver stiffness measurement using FibroScan in chronic hepatitis C in South Korea: a multicenter, prospective study.
|
J Gastroenterol Hepatol
|
2011
|
0.92
|
|
31
|
Rescue monotherapy in lamivudine-resistant hepatitis B e antigen-positive chronic hepatitis B: adefovir versus entecavir.
|
Antivir Ther
|
2009
|
0.89
|
|
32
|
Clinical efficacy of a 24-months course of lamivudine therapy in patients with HBeAg negative chronic hepatitis B: a long-term prospective study.
|
J Korean Med Sci
|
2010
|
0.87
|
|
33
|
The clinical impact of early detection of the YMDD mutant on the outcomes of long-term lamivudine therapy in patients with chronic hepatitis B.
|
Antivir Ther
|
2006
|
0.87
|
|
34
|
Survival of hepatocellular carcinoma patients may be improved in surveillance interval not more than 6 months compared with more than 6 months: a 15-year prospective study.
|
J Clin Gastroenterol
|
2013
|
0.86
|
|
35
|
High effectiveness of peginterferon alfa-2a plus ribavirin therapy in Korean patients with chronic hepatitis C in clinical practice.
|
Clin Mol Hepatol
|
2013
|
0.85
|
|
36
|
[A case of duodenal adenocarcinoma arising from the heterotopic pancreas].
|
Korean J Gastroenterol
|
2003
|
0.84
|
|
37
|
The significance of ICG-R15 in predicting hepatic toxicity in patients receiving radiotherapy for hepatocellular carcinoma.
|
Liver Int
|
2012
|
0.84
|
|
38
|
Clevudine-induced viral response, associated with continued reduction of HBsAg titer, was durable after the withdrawal of therapy.
|
J Gastroenterol
|
2010
|
0.84
|
|
39
|
Clinical outcomes and prognostic factors of patients with advanced hepatocellular carcinoma treated with sorafenib as first-line therapy: a Korean multicenter study.
|
J Gastroenterol Hepatol
|
2014
|
0.82
|
|
40
|
A peroxisome-proliferator activated receptor-gamma ligand could regulate the expression of leptin receptor on human hepatic stellate cells.
|
Histochem Cell Biol
|
2007
|
0.82
|
|
41
|
External validation of P2/MS and comparison with other simple non-invasive indices for predicting liver fibrosis in HBV-infected patients.
|
Dig Dis Sci
|
2009
|
0.82
|
|
42
|
Treatment outcome of transcatheter arterial chemoinfusion according to anticancer agents and prognostic factors in patients with advanced hepatocellular carcinoma (TNM stage IVa).
|
Yonsei Med J
|
2004
|
0.81
|
|
43
|
Antifibrotic effects of magnesium lithospermate B on hepatic stellate cells and thioacetamide-induced cirrhotic rats.
|
Exp Mol Med
|
2011
|
0.81
|
|
44
|
Quasispecies and pre-existing drug-resistant mutations of hepatitis B virus in patients with chronic hepatitis B.
|
Gut Liver
|
2013
|
0.80
|
|
45
|
Efficacy and safety of entecavir plus carnitine complex (GODEX®) compared to entecavir monotherapy in patient with ALT elevated chronic hepatitis B: randomized, multicenter open-label trials. The GOAL study.
|
Clin Mol Hepatol
|
2013
|
0.79
|
|
46
|
[Usefulness of urinary trypsinogen-2 dipstick test for diagnosis of acute pancreatitis].
|
Korean J Gastroenterol
|
2004
|
0.78
|
|
47
|
Salvage chemotherapy with docetaxel and epirubicin for advanced/metastatic gastric cancer.
|
Oncology
|
2008
|
0.78
|
|
48
|
Clinical course of virologic breakthrough after emergence of YMDD mutations in HBeAg-positive chronic hepatitis B.
|
Intervirology
|
2008
|
0.78
|
|
49
|
[Clevudine therapy in patients with chronic hepatitis B].
|
Korean J Hepatol
|
2009
|
0.77
|
|
50
|
p53 and p21WAF1/CIP1 in hepatitis B virus related hepatocarcinogenesis.
|
Hepatogastroenterology
|
2003
|
0.77
|
|
51
|
Individual prediction model for lamivudine treatment response in hepatitis B virus e antigen-positive chronic hepatitis B patients.
|
J Gastroenterol Hepatol
|
2014
|
0.77
|
|
52
|
Combined effects of an antioxidant and caspase inhibitor on the reversal of hepatic fibrosis in rats.
|
Apoptosis
|
2013
|
0.76
|
|
53
|
A single adenovirus-mediated relaxin delivery attenuates established liver fibrosis in rats.
|
J Gene Med
|
2016
|
0.76
|
|
54
|
[Clinical outcomes of systemic chemotherapy in hepatocellular carcinoma patients with multiple lung metastases].
|
Korean J Hepatol
|
2008
|
0.76
|
|
55
|
Toll-like receptor polymorphisms are not associated with liver cirrhosis in hepatitis B virus infected Korean patients.
|
Hepatogastroenterology
|
2011
|
0.76
|
|
56
|
Progression of diet induced nonalcoholic steatohepatitis is accompanied by increased expression of Kruppel-like-factor 10 in mice.
|
J Transl Med
|
2014
|
0.75
|
|
57
|
Assessment of the efficacy of reducing peginterferon alpha-2a and ribavirin dose on virologic response in Koreans with chronic hepatitis C.
|
Korean J Intern Med
|
2009
|
0.75
|
|
58
|
[Acute hepatitis A complicated with acute kidney injury].
|
Korean J Gastroenterol
|
2010
|
0.75
|
|
59
|
Efficacy and long-term follow up of combination therapy with interferon alpha and ribavirin for chronic hepatitis C in Korea.
|
Yonsei Med J
|
2006
|
0.75
|
|
60
|
Pyloric Brunner's gland hamartoma.
|
Gastrointest Endosc
|
2004
|
0.75
|
|
61
|
[Clinical features and prognostic factors of fulminant hepatic failure in Koreans].
|
Korean J Hepatol
|
2004
|
0.75
|
|
62
|
Association between polymorphism of tumor necrosis factor-alpha promoter and response to lamivudine treatment in patients with chronic hepatitis B.
|
Dig Dis Sci
|
2009
|
0.75
|
|
63
|
Impact of postoperative hepatitis B virus reactivation in hepatocellular carcinoma patients who formerly had naturally suppressed virus.
|
J Gastroenterol Hepatol
|
2014
|
0.75
|
|
64
|
Prediction of esophageal variceal bleeding in B-viral liver cirrhosis using the P2/MS noninvasive index based on complete blood counts.
|
Digestion
|
2012
|
0.75
|
|
65
|
[Usefulness and safety of extracorporeal liver support therapy using MARSR for patients with liver failure: a preliminary report].
|
Korean J Gastroenterol
|
2009
|
0.75
|
|
66
|
Duodenal metastatic amelanotic melanoma.
|
Gastrointest Endosc
|
2003
|
0.75
|
|
67
|
Entecavir plus adefovir versus adefovir plus lamivudine in hepatitis B virus e antigen-positive, lamivudine-resistant chronic hepatitis B.
|
J Gastroenterol Hepatol
|
2014
|
0.75
|
|
68
|
Clinical characteristics of acute hepatitis A complicated by acute kidney injury.
|
Scand J Infect Dis
|
2011
|
0.75
|
|
69
|
[Type of electric currents used for standard endoscopic sphincterotomy does not determine the type of complications].
|
Korean J Gastroenterol
|
2004
|
0.75
|
|
70
|
Antiviral Therapy in Patients With Chronic Hepatitis C-related Hepatocellular Carcinoma Responding to Palliative Treatment.
|
J Clin Gastroenterol
|
2017
|
0.75
|